XML 92 R78.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation - Restricted and Performance Stock Units Granted (Details)
shares in Thousands
12 Months Ended
Dec. 31, 2022
$ / shares
shares
Restricted Stock Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Non-Option equity instruments outstanding, beginning balance (in shares) | shares 1,596
Non-Option equity instruments, granted (in shares) | shares 933
Non-Option equity instruments, vested (in shares) | shares (588)
Non-Option equity instruments, canceled (in shares) | shares (386)
Non-Option equity instruments outstanding, ending balance (in shares) | shares 1,555
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Equity instruments other than options, nonvested, weighted average grant date fair value (in USD per share) | $ / shares $ 42.71
Equity instruments other than options, grants in period, weighted average grant date fair value (in USD per share) | $ / shares 27.77
Equity instruments other than options, vested in period, weighted average grant date fair value (in USD per share) | $ / shares 41.72
Equity instruments other than options, canceled, weighted average grant date fair value (in USD per share) | $ / shares 42.88
Equity instruments other than options, nonvested, weighted average grant date fair value (in USD per share) | $ / shares $ 34.08
Performance-based restricted stock units  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Non-Option equity instruments outstanding, beginning balance (in shares) | shares 1,377
Non-Option equity instruments, granted (in shares) | shares 88
Non-Option equity instruments, vested (in shares) | shares (196)
Non-Option equity instruments, canceled (in shares) | shares (651)
Non-Option equity instruments, actual adjustment for certified performance periods (in shares) | shares 26
Non-Option equity instruments outstanding, ending balance (in shares) | shares 644
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Equity instruments other than options, nonvested, weighted average grant date fair value (in USD per share) | $ / shares $ 35.96
Equity instruments other than options, grants in period, weighted average grant date fair value (in USD per share) | $ / shares 27.74
Equity instruments other than options, vested in period, weighted average grant date fair value (in USD per share) | $ / shares 37.57
Equity instruments other than options, canceled, weighted average grant date fair value (in USD per share) | $ / shares 37.17
Equity instruments other than options, actual adjustment for certified performance periods, weighted average fair value (in USD per share) | $ / shares 49.78
Equity instruments other than options, nonvested, weighted average grant date fair value (in USD per share) | $ / shares $ 32.40